The effects and reliability of a simple method of contrast two-dimensional echocardiographic delineation of myocardium after intracoronary injections were evaluated in closed-chest dogs. Multiple injections of an agitated saline-Renografin (meglumine diatrizoate) mixture (3:2 ratio, 2-ml bolus) into the left main coronary artery as well as at different sites of the left anterior descending and circumflex coronary arteries were studied in several short-axis and long-axis cross sections of the left ventricle. These contrast injections opacified specific regions of left ventricular myocardium depending on the site of injection. Contrast injection into the left main coronary artery provided a clear, echo-free outline (negative contrast) of underperfused myocardium distal to the coronary occlusion. Reproducibility studies of the extent of involved zones measured in echocardiographic cross sections indicated high intraand interobserver correlation coefficients (r = 0.97 and 0.97). The effects of the intracoronary injection of contrast material appeared minor and brief. ECG ST-T changes lasted 49.4 ± 36.7 seconds, aortic systolic pressure was reduced by 7.6 ± 4.4% for 18.9 ± 4.8 seconds, and the peak rate of left ventricular pressure rise decreased by 14.3 ± 2.6%, but returned to control levels within 19.4 ± 6.1 seconds. The zone of left ventricular asynergy after coronary occlusions was also delineated by cross-sectional echocardiography and corresponded to the contrast-outlined underperfused zone (negative contrast). This new intracoronary echocardiographic technique has only minor hemodynamic consequences and provides reliable quantitation of underperfused and dysfunctioning zones after experimental coronary occlusions. Further investigation and validation of this method may provide useful characterization of the extent and severity of myocardial ischemia and infarction.
THE PRIMARY application of contrast echocardiography has been in qualitative studies of the heart and determination of intracardiac defects or shunts'6 and assessment of tricuspid regurgitation.7-"0 The concept of injecting contrast material into the cardiac chambers and analyzing contrast washout in echocardiographic images has been examined in the hope of providing a noninvasive measurement of blood flow. "I Only scant attention has been given to the potential of contrast echocardiography for study of the extent or degree of myocardial underperfusion.I' 12 Various agents, ranging from carbonated water, saline and indocyanine green to gelatin-encapsulated microbubbles, have been tried in experimental intracoronary injections, but the resulting delineation of ischemic myocardium appeared variable, and the reliability of measurements of extent of involved cardiac muscle has not been systematically evaluated."' 12 Efforts are under way to devel-op appropriate microbubbles or fluids that can safely cross the lung and permit study of left ventricular and septal myocardium while being injected intravenously or into the right chamber."'-"'
We developed a simple myocardial contrast echocardiographic method that could be readily applied in closed-chest dogs with coronary occlusions. When it appeared that intracoronary injection of an agitated mixture of saline and Renografin (meglumine diatrizoate) provided consistent myocardial opacification and satisfactory outline of acutely ischemic and dysfunctioning myocardium in two-dimensional crosssectional images, we undertook to evaluate the reliability and reproducibility of this method. We also assessed the degree and duration of any hemodynamic and functional effects due to intracoronary injection of contrast material.
Methods
Seven closed-chest dogs that weighed 25-44 kg (mean 31 kg) were studied. The dogs were anesthetized with morphine, 2 mg/kg i.m., and sodium pentobarbital, 30 mg/kg i.v., and ventilated with a Harvard respirator and a cuffed endotracheal tube. A #8F catheter was inserted into the right femoral artery and advanced to the ascending aorta; a pigtail catheter was introduced retrogradely into the left ventricle through the left femoral artery. Aortic and left ventricular pressures were measured with fluid-filled catheters and Statham P23Db pressure transducers. Maximal left ventricular dP/dt was obtained with a resistance-capacitance differentiation circuit. Pressures, left ventricular dP/dt, and a precordial ECG were monitored and recorded on a physiologic multichannel recorder (Electronics for Medicine model V12, Honeywell) at a paper speed of 25 or 50 mm/sec. A #9F angiographic catheter was placed in the left main coronary artery under fluoroscopic control and a #4F balloon catheter was passed through its lumen and placed into a branch.
Two-dimensional Echocardiographic Examination
A mechanical ultrasonic sector scanner (ATL Mark III) was used in the two-dimensional echocardiographic studies. Echocardiographic examination of the heart was standardized in closed-chest dogs to achieve optimal cross-sectional images, as previously reported.'6 Multiple short-axis cross sections of the left ventricle were recorded at the level of the mitral valVe leaflets, at high or middle and low levels of the papillary muscles, and at the apex. A left ventricular long-axis view was also recorded.
All short-axis and long-axis views of the left ventricle were recorded on videotape, and the images could be replayed in real-time, slow motion, or as single frames. The two-dimensional echocardiographic analysis consisted of outlining the endocardium in cross section from a still frame and reviewing the dynamic image by video replay to correct errors in the outlined interfaces. This method provides a high degree of reproducibility of two-dimensional echocardiographic measurements for quantitating cardiac function. [17] [18] [19] Wall motion analysis of the left ventricle was performed in the four short-axis views using a "floating" reference system that has two reference points. The center of the section and the inferior junction of the right ventricle with ventricular septum were used as internal landmarks, and provided an indexing line required for standardized computer-aided subdivisions. Endocardial and epicardial outlines of sections were studied in end-diastole (onset of QRS on the ECG) and in end-systole (smallest intracavitary size of section). By superimposing end-diastolic and end-systolic outlines, regions of hypokinesis, akinesis or dyskinesis could be examined and analyzed in 16 equal segments ( fig. 1 ). The radial division method used a polar coordinate system; the center was the center of division and the polar axis was the line connecting the center of division and the first reference point. Segmental and global contractile function were assessed from computations of percent fractional area changes (FACs), as previously reported. 18 21, 22 Myocardial Opacification by Contrast Echocardiogram Two-dimensional echocardiography after intracoronary injections of a contrast material was used to define the zone of severely underperfused myocardium based on regional differences in left ventricular wall echo intensity. The contrast material was a 3:2 mixture of saline and Renografin, agitated by mixing during passage through a three-way stopcock. This agitation probably generated microbubbles, which facilitated visualization of opacified myocardium. Limited trialand-error checks indicated that a mixture of three parts saline to two parts Renografin provided the most consistent opacification. Approximately 2 ml of the con- trast mixture were injected manually as a bolus. Appearance of the contrast effect within a myocardial segment, as well as its rate of disappearance, could be studied with continuous recordings of two-dimensional echocardiograms. Several minutes after disappearance of the contrast effect, the contrast material was injected again at the same site to establish the reproducibility of the technique in terms of its ability to delineate the extent of myocardial opacification. Contrast material was injected into the left main coronary artery (LMC), just beyond the origin of the left anterior descending coronary artery (LAD) or left circumflex coronary artery (LCx), and distally within these branches of the left coronary artery. Injection into the LMC, and proximally into the LAD or LCx, was made through a #9F angiographic catheter. The distal coronary artery injections were through a #4F catheter that was equipped with a balloon and a central lumen20 and threaded through the angiographic catheter. The intracoronary catheter position was checked by cinefluoroscopy.
Two-dimensional echocardiograms were initially recorded in the control state and before, during and after injection of contrast microbubbles from different sites in the coronary arteries. Then, a coronary artery branch was occluded by inflating the intracoronary balloon.20 The site and the completeness of occlusion were demonstrated by coronary angiography. After coronary occlusion, injection of contrast material was repeated through the LMC using the #9F angiographic catheter. The extent of myocardium perfused by a particular branch of the coronary artery was assessed in two ways: by the positive contrast echo outline after injection into the coronary artery branch and, after the branch occlusion, by a negative contrast echo outline upon injection of contrast material into the LMC. The extent of perfused myocardium was compared with the subsequent area of asynergy after coronary occlusion. The extent of myocardium outlined by contrast echoes 586 CIRCULATION MYOCARDIAL CONTRAST ECHOCARDIOGRAPHY/Tei et al. was measured at end-diastole and was expressed as the angle subtended by the margins of the contrastfilled segment of the myocardium. To characterize global and segmental ventricular function, systolic FACs were computed for each short-axis cross section and for individual segments, including segments in which perfusion was diminished by coronary artery occlusion.
Observer Variability of Measurements
To test the interobserver variability in echocardiographic measurements of the extent of contrast-outlined segments of the myocardial wall, two observers independently measured these areas from the same still video frame. Intraobserver variability was also assessed by a single observer examining the same videotape recording on two separate occasions. The interobserver and intraobserver variability were tested in 28 cross sections in seven dogs. Linear regression analysis was perforned and the standard error of the estimate calculated. For each paired measurement, the percent error from an average was calculated to derive a mean percent error.
Repeatability of the Contrast Technique
To test the repeatability of contrast appearance in the myocardium, the echocardiographic studies were performed twice at each of the four levels on short-axis sections during multiple contrast injections from the same intracoronary site in seven dogs.
Statistical Analysis
The statistical significance of the observed changes was analyzed using the paired t test.
Results
Contrast echocardiograms of the myocardium were obtained by intracoronary injection of the agitated mixture of saline and Renografin, and appeared as an enhanced echo intensity in the left ventricular wall. Such myocardial contrast opacification was observed consistently, and the effect persisted for about 30 seconds. Figure 2 shows myocardial opacification of the entire cross section at the midpapillary level resulting from injection of saline and Renografin into the LMC of a normal closed-chest dog. In all seven dogs in this study, two-dimensional short-axis and long-axis cross sections showed that the left ventricular myocardium was uniformly filled with contrast echoes after injections into the LMC. Selective injections into the LAD or LCx resulted in contrast echo opacification of localized regions of the left ventricle. Figure 3 shows the fig. 4 ).
Reproducibility of Measurements of Contrast-outlined Myocardium
Two contrast injections were performed and the extent of the myocardium outlined by contrast echoes was analyzed. Comparison of results from these duplicate measurements correlated well (r = 0.93), which indicates that this technique of myocardial opacification is repeatable. The mean percent variation of these repeat measurements was 4.4 + 3.5%. After a single injection of contrast material, the resulting echocardiogram was analyzed by the same observer on two separate occasions. The intraobserver reproducibility of contrast echo delineation was satisfactory (r = 0.97, mean percent error 3.7 ± 2.2%). When two observers independently analyzed a given contrast echocardiogram, their measurements of the contrast-outlined area also correlated well (r = 0.97, mean percent error 3.7 ± 2.4%). This region of asynergy corresponds to the myocardial area outlined by contrast echoes on the cross section at the same level. This relationship was studied in more detail by computing the FAC in each of the 16 equal segments. Figures 6A and 6B show comparisons of the regional extent of contrast opacified myocardium and the extent of asynergy in the same echocardiographic cross section. The segmental FAC of the contrast-outlined region was significantly depressed after occlusion of the coronary artery. The segments that exhibit reduced contraction in the underperfused zones were also visualized by the contrast echocardiogram obtained from the same site before coronary occlusion.
There was not a sharp correlation between the contrast perfused area and the change in FAC. Furthermore, injection of contrast material into the LMC after a selective coronary occlusion resulted in a "negative" contrast outline of the corresponding area exhibiting segmental asynergy ( fig. 7) . Table I shows data on global FAC of two-dimen- 37.8± 10.1 13.5± 11.3 p < 0.001 p < 0.001 Abbreviations: FAC = fractional area change; LAD = left anterior descending coronary artery; LCx = left circumflex coronary artery; MV = mitral valve; HPM = high papillary muscle; MPM = midpapillary muscle; LPM = low papillary muscle. sional echocardiographic short-axis cross sections before and after coronary occlusion, as well as the FAC of the underperfused myocardial region outlined by negative contrast echoes. Both the total cross section and the underperfused region exhibited significant reductions in FAC after the coronary occlusion (p < 0.001). However, the underperfused segments showed a significantly more severe mean reduction of FAC than the overall cross section (65.1% vs 32.9%). In some instances, coronary occlusion resulted in regional dyskinesis, reflected in negative value of segmental FAC. Table 2 shows changes of heart rate, ECG, aortic pressures and left ventricular peak dP/dt during injection of contrast material into the coronary artery. Heart rate increased by 8.0 + 6.3% (p < 0.001), systolic and diastolic aortic pressure decreased by 7.6 4.4% (p < 0.001) and 7.0 + 4.0% (p < 0.01), respectively, peak left ventricular dP/dt decreased by 14.3 + 2.6% (p < 0.001) and left ventricular end-diastolic pressure increased from 3.4 ± 5.2 to4.4 ± 5.0 mm Hg. These changes returned to the control values within 33 seconds. ECG changes after injection of contrast material consisted of T-wave inversions in six dogs and ST depression in one dog; these changes returned to control levels by an average of 49.4 ± 36.7 seconds. No ectopy was observed during this period in any of the seven dogs. The time to maximal decline was not significantly different between the ECG, aortic pressure and peak left ventricular dP/dt.
Total section FACs were measured at the midpapillary muscle level of left ventricular short-axis cross sections before injection of microbubbles, during myocardial opacification at the time of maximal ECG changes and 1 minute after the intracoronary injections of the contrast material. No significant changes in total FAC were noted.
Discussion
Armstrong and co-workers23 assessed myocardial perfusion using contrast-enhanced two-dimensional echocardiography and gelatin-encapsulated microbubbles. These investigators measured echocardiographic contrast intensity in a single cross section of the left ventricle before and after injections of the contrast agent into the aortic root in open-chest dogs. They compared the measured changes in echo intensities with assessment of myocardial perfusion by radioactive microspheres. Although echocardiographic enhancement correlates generally with percent flow reduction was noted, a linear correlation with absolute flow could not be demonstrated. Wall motion abnormalities in their study did not serve as well as contrast echocardiography as a marker for lowand normalflow regions, but they did not examine a relationship between regional echocardiographic contrast enhancement and segmental wall motion, as was done in the present study. The authors explain the wide scatter of echocardiographic contrast enhancement values by pointing to limitations of the design of their experiments. These included the use of open-chest dogs, the use of constant gain settings throughout the experiment, and a probable nonuniform distribution of microbubbles within the aortic root injection site. Despite these limitations, Armstrong and associates23 have taken an important step by correlating the myocardial echocardiographic contrast enhancement and an independent measurement of myocardial perfusion. An obvious limitation of gelatin-encapsulated microbubbles is the paucity of knowledge of their toxicologic and pharmacologic effects. Furthermore, although the authors commented on a lack of adverse hemodynamic or electrocardiographic effects attributable to the infusion of gelatin-encapsulated microbubbles, no systemic examination of the magnitude and time course of these changes was attempted.
The present study differs from the study of Armstrong et al. 23 in several aspects. We developed a contrast agent consisting of an agitated mixture of Renografin and saline. The effects of selective Renografin injections in the coronary circulation are widely known. However, additional studies will have to be No 3, MARCH 1983 designed to assess the sizes of microbubbles produced by agitations and their fate in the capillary bed. Since the myocardial opacification in our study lasted approximately 30 seconds, the precise mechanism for this extended persistence will have to be explored. Thus, a possible role of transient blockage of capillaries by microbubbles as opposed to transcapillary migration will need to be examined. The present study in closed-chest dogs used multiple echocardiographic cross sections to compare the extent of asynergy with the size of contrast-enhanced myocardial segments after injection of contrast material at the site of subsequent coronary artery occlusion. We could examine the extent of asynergy with the extent of negative contrast delineation from the injection in the LMC after a branch occlusion. Our approach, therefore, provided a generally good correlation between the contrast-enhanced myocardium and asynergy from subsequent occlusion, although a sharp correlation was not observed.
An agitated mixture of saline and Renografin not only provided a consistently effective myocardial contrast agent, but also simultaneously demonstrated coronary anatomy by cinefluoroscopic visualization. A systematic examination of electrocardiographic hemodynamic and functional variables demonstrated lack of dysrhythmias during the contrast injection, minor ST-T-wave changes peaking at a mean of 9.3 seconds and returning to control levels within a mean of 49.4 seconds, decrease of aortic systolic pressure and of left ventricular peak dP/dt by less than 15% during the injection and return to control in less than 1 minute, minimal increase (1 mm Hg) in left ventricular enddiastolic pressure returning to baseline in 30 seconds, and absence of significant alterations in the total FACs in the short-axis cross sections.
We speculate that the extent of myocardial opacification achieved by the echocardiographic contrast enhancement is related to myocardial perfusion. The present study demonstrates concordance of quantitative estimates of the extent of underperfused myocardium (either by positive or negative contrast effects) and the extent of ischemic asynergy. Further studies are under way in our laboratory to correlate the extent of myocardial segments determined by contrast-enhanced two-dimensional echocardiography with anatomic assessment of underperfusion and evidence of ischemic damage from coronary arterial occlusions.
The precise mechanisms of contrast echocardiographic enhancement are poorly understood. Although introduction of microbubbles formed by vigorous agitation of solutions is probably implicated, other possibilities include cavitation, turbulence, temperature differences and differential acoustic impedance of heterogenous mixtures. Further studies will be required to elucidate the mechanisms of contrast effects produced by the agent described in this study. Because agitated saline or Renografin alone did not provide adequate and consistent contrast effects, the persistence of microbubbles may be aided by the acoustically heterogenous solution. Additional in vitro and in vivo stud-ies are under way to elucidate these mechanisms. Finally, although our preliminary studies attest to the safety of this contrast agent, considerable further documentation of the presence and size of microbubbles as well as of safety in experimental simulations of critical coronary artery occlusions will be required before attempting its application in man.
Contrast echocardiography appears to offer several advantages over the current techniques such as thallium scintigraphy in the study of regional blood flow. The higher resolution of echocardiography, the ability to make frequent and serial studies, and the ability to obtain real-time information are likely to enhance the method's attractiveness. Contrast echocardiography could be performed in conjunction with cardiac catheterization to assess the functional significance of an anatomic lesion.
